Axon (AXON) director receives 611 restricted stock units in equity grant

Rhea-AI Filing Summary

Morgenfeld Todd R reported acquisition or exercise transactions in this Form 4 filing.

Axon Enterprise director Todd R. Morgenfeld received an equity grant of 611 shares of Common Stock in the form of time-vested restricted stock units. The units were granted at no cash cost and increase his direct holdings to 947 shares. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Morgenfeld Todd R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	611	$0.00	--

Holdings After Transaction: Common Stock — 947 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 611 shares Total shares after grant: 947 shares Grant price per share: $0.00 per share

3 metrics

RSUs granted 611 shares Time-vested restricted stock units granted to director

Total shares after grant 947 shares Director’s direct holdings following transaction

Grant price per share $0.00 per share Equity award granted at no cash cost

Key Terms

restricted stock units, Amended and Restated 2022 Stock Incentive Plan, Annual Meeting of Shareholders

3 terms

restricted stock units financial

"Time-vested restricted stock units granted to the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated 2022 Stock Incentive Plan financial

"granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan"

Annual Meeting of Shareholders financial

"the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morgenfeld Todd R

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/29/2026		A		611(1)	A	$0	947	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.

Remarks:

	/s/ Todd Morgenfeld by Isaiah Fields, Attorney-in-Fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Axon (AXON) report for Todd R. Morgenfeld?

Axon reported that director Todd R. Morgenfeld received 611 time-vested restricted stock units of Common Stock as an equity grant, at no cash cost, increasing his direct holdings to 947 shares following the award.

How many Axon (AXON) shares does Todd R. Morgenfeld hold after this grant?

After the grant of 611 restricted stock units, Todd R. Morgenfeld directly holds 947 shares of Axon Common Stock, according to the Form 4, reflecting his updated ownership position following this equity award.

What type of equity award did Axon (AXON) grant to Todd R. Morgenfeld?

Todd R. Morgenfeld received time-vested restricted stock units representing 611 shares of Axon Common Stock. These units were granted under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan as part of his director compensation.

When do Todd R. Morgenfeld’s Axon (AXON) restricted stock units vest?

The 611 time-vested restricted stock units granted to Todd R. Morgenfeld are scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.

Did Todd R. Morgenfeld buy Axon (AXON) shares on the open market?

No. The Form 4 shows a grant of 611 restricted stock units at a price of $0.00 per share, indicating a compensation-related equity award rather than an open-market purchase of Axon Common Stock.